Topical and systemic retinoids for the treatment of cutaneous viral warts: A systematic review and meta-analysis.
HPV
cutaneous
retinoids
viral
warts
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
01
11
2020
revised:
18
11
2020
accepted:
01
12
2020
pubmed:
6
12
2020
medline:
25
5
2021
entrez:
5
12
2020
Statut:
ppublish
Résumé
Cutaneous viral warts (CVW), caused by human papillomavirus, often have a self-limited course. However, some patients experience a recalcitrant disease despite treatment. Retinoids are considered the mainstay of therapy in many dermatologic diseases. Data on their use for viral warts are limited. To systematically review the published evidence on the efficacy and safety of retinoids for the treatment of CVW. A systematic review and meta-analysis of topical or systemic retinoid treatment for CVW was performed in accordance with the PRISMA statement. The primary outcome was clinical response; secondary outcomes were recurrence rate and adverse events. Fourteen publications including 399 patients treated exclusively with retinoids (65% topical, 35% systemic) were evaluated. The complete response rate was 64% (95% CI, 46-78%; I
Substances chimiques
Retinoids
0
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14637Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Sterling JC, Gibbs S, Haque Hussain SS, et al. British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171(4):696-712.
Bruggink SC, Eekhof JA, Egberts PF, et al. Natural course of cutaneous warts among primary schoolchildren: a prospective cohort study. Ann Fam Med. 2013;11(5):437-441.
Leman JA, Benton EC. Verrucas: guidelines for management. Am J Clin Dermatol. 2000;1(3):143-149.
Dall'oglio F, D'Amico V, Nasca MR, et al. Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2012;13(2):73-96.
Lipke MM. An armamentarium of wart treatments. Clin Med Res. 2006;4(4):273-293.
Veien NK, Madsen SM, Avrach W, et al. The treatment of plantar warts with a keratolytic agent and occlusion. J Dermatol Treat. 1991;2(2):59-61.
Bourke JF, Berth-Jones J, Hutchison PE. Cryotherapy of common viral warts at intervals of 1, 2 and 3 weeks. Br J Dermatol. 1990;132(3):115-120.
Street ML, Roenigk RK. Recalcitrant periungal verrucae: the role of carbon dioxide laser vaporisation. J Am Acad Dermatol. 1990;23(1):115-120.
Fichman Y, Levi A, Hodak E, et al. Efficacy of pulsed dye laser treatment for common warts is not influenced by the causative HPV type: a prospective study. Lasers Med Sci. 2018;33(4):773-777.
Stender IM, Na R, Fogh H, et al. Photodynamic therapy with 5 aminolaevulinic acid or placebo for recalcitrant foot and hand warts; a randomized double-blind trial. Lancet. 2000;355(9208):963-966.
Shelley WB, Shelley ED. Intralesional bleomycin sulfate therapy for warts. A novel bifurcated needle puncture technique. Arch Dermatol. 1991;127(2):234-236.
Glass AT, Solomon BA. Cimetidine therapy for recalcitrant warts in adults. Arch Dermatol. 1996;132(6):680-682.
Thomson S. The treatment of plantar warts by formalin. Br J Dermatol. 1943;55(11):267-269.
Hirose R, Hori M, Shukuwa T, et al. Topical treatment of resistant warts with gluteraldehyde. Dermatology. 1994;21(4):248-253.
Kaur GJ, Brar BK, Kumar S, et al. Evaluation of the efficacy and safety of oral isotretinoin versus topical isotretinoin in the treatment of plane warts: a randomized open trial. Int J Dermatol. 2017;56(12):1352-1358.
Jason J, Archibald LK, Nwanyanwu OC, et al. Vitamin A levels and immunity in humans. Clin Diagn Lab Immunol. 2002;9(3):616-621.
Bartsch D, Boye B, Baust C, et al. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J. 1992;11(6):2283-2291.
Faluhelyi Z, Rodler I, Csejtey A, et al. All-trans retinoic acid (ATRA) suppresses transcription of human papillomavirus type 16 (HPV16) in a dose-dependent manner. Anticancer Res. 2004;24(2B):807-809.
Akyol M, Ozçelik S. Non-acne dermatologic indications for systemic isotretinoin. Am J Clin Dermatol. 2005;6(3):175-184.
Orfanos CE, Zouboulis CC, Almond-Roesler B, et al. Current use and future potential role of retinoids in dermatology. Drugs. 1997;53(3):358-388.
Coble BI, Dahlgren C, Molin L, et al. Neutrophil function in psoriasis: effects of retinoids. Acta Derm Venereol. 1987;67(6):481-490.
Goldsmith LA, Weinrich AE, Shupack J. Pityriasis rubra pilaris response to 13-cis- retinoic acid (isotretinoin). J Am Acad Dermatol. 1982;6(4 Pt 2 Suppl):710-715.
Moon TE, Levine N, Cartmel B, et al. Retinoids in prevention of skin cancer. Cancer Lett. 1997;114(1-2):203-205.
Weninger W, Rendl M, Mildner M, et al. Retinoids downregulate vascular endothelial growth factor/vascular permeability factor production by normal humankeratinocytes. J Invest Dermatol. 1998;111(5):907-911.
Molin L, Thomsen K, Volden G, et al. Oral retinoids in mycosis fungoides and Sezary syndrome: a comparison of isotretinoin and etretinate: a study from the Scandinavian Mycosis Fungoides Group. Acta Derm Venereol. 1987;67(3):232-236.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Kwok CS, Holland R, Gibbs S. Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials. Br J Dermatol. 2011;165(2):233-246.
Higgins JPT, Altman DG, Gøtzsche PC, et al. Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomized trials. BMJ. 2011;343:d5928.
Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. Ottawa Hospital Research Institute, 2017.
al Aboosi M. Treatment of plane warts by tretinoin-induced irritant reaction. Int J Dermatol. 1994;33(11):826-827.
de Bersaques J. Vitamin A acid in the topic treatment of plantar warts. Dermatologica. 1975;150(6):369-371.
Kubeyinje EP. Evaluation of the efficacy and safety of 0.05% tretinoin cream in the treatment of plane warts in Arab children. J Dermatol Treat. 1996;7(1):21-22.
Gupta R. Plantar warts treated with topical adapalene. Indian J Dermatol. 2011;56(5):513-514.
Gupta R, Gupta S. Topical adapalene in the treatment of plantar warts; randomized comparative open trial in comparison with cryo-therapy. Indian J Dermatol. 2015;60(1):102.
Fadheel BM, Saleeh HR. Evaluation of Isotretinoin gel and oral zinc sulphate in the treatment of plane warts. J Fac Med Baghdad. 2008;50(4):448-450.
Hason AJ, Salman HA, Al-Akkam EJ. Treatment of facial plane warts, a comparative study of topical 5% KOH solution with topical 0.05% tretinoin cream. Iraqi J Comm Med. 2018;31(3):122-127.
El-Refaei AM, Abd ER, Sherine H. Citric acid 50% solution versus tretinoin 0.05% lotion in the treatment of plane warts. J Egypt Women Dermatol Soc. 2015;12(2):113-119.
Nofal A, Elkot R, Nofal E, et al. Combination therapy versus monotherapy in the treatment of recalcitrant warts: a clinical and immunological study. J Cosmet Dermatol. 2018;18(5):1448-1455. https://doi.org/10.1111/jocd.12848.
Olguin-García MG, Jurado-Santa Cruz F, Peralta-Pedrero ML, et al. A double-blind, randomized, placebo-controlled trial of oral isotretinoin in the treatment of recalcitrant facial flat warts. J Dermatolog Treat. 2015;26(1):78-82.
Gelmetti C, Cerri D, Schiuma AA, et al. Treatment of extensive warts with etretinate: a clinical trial in 20 children. Pediatr Dermatol. 1987;4(3):254-258.
Al-Hamamy HR, Salman HA, Abdulsattar NA. Treatment of plane warts with a low-dose oral isotretinoin. ISRN Dermatol. 2012;2012, 163929. https://doi.org/10.5402/2012/163929.
Nofal A, Khattab F, Nofal E, et al. Combined acitretin and Candida antigen versus either agent alone in the treatment of recalcitrant warts. J Am Acad Dermatol. 2018;79(2):377-378.
Brodell RT, Johnson SM. Warts: Diagnosis and Management: An Evidence-Based Approach. New York: Martin Dunitz; 2003.
Sterling JC, Handfield-Jones S, Hudson PM. British Association of Dermatologists. Guidelines for the management of cutaneous warts. Br J Dermatol. 2001;144(1):4-11.
Snast I, Kaftory R, Lapidoth M, et al. Combined pulsed dye laser and systemic retinoids for the treatment of hypertrophic resistant warts among organ transplant patients. Lasers Med Sci. 2020;35(7):1653-1657. https://doi.org/10.1007/s10103-020-03011-4.
Törmä H. Regulation of keratin expression by retinoids. Dermatoendocrinol. 2011;3(3):136-140.
Dave DD, Abdelmaksoud A. Low dose isotretinoin as an adjuvant therapy for treatment of different clinical variants of warts: a case series. Dermatol Ther. 2019;32(2):e12836. https://doi.org/10.1111/dth.12836.
Abdelmaksoud A, Vestita M, El-Amawy HS, et al. Systemic isotretinoin therapy in the era of COVID-19. Dermatol Ther. 2020;33(4):e13482. https://doi.org/10.1111/dth.13482.